EGRP-Supported Health Disparities Research


Overview

The National Cancer Institute (NCI) has targeted the reduction of cancer-related health disparities as an important challenge. Health disparities are differences in the incidence, prevalence, mortality, and burden of cancer and related adverse health conditions that exist among specific population groups in the United States. These population groups may be characterized by gender, age, ethnicity, education, income, social class, disability, geographic location, or sexual orientation. The goal is to understand the causes of health disparities in cancer and develop effective interventions to reduce or eliminate them.

Return to Top

Funding Opportunities

NCI-sponsored Funding Opportunity Announcements (FOAs) related to health disparities include:

  • Minority Patient-Derived Xenograft (PDX) Development and Trial Centers - expires January 19, 2018
  • Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities - expires January 19, 2018
  • The Health of Sexual and Gender Minority (SGM) Populations - expires May 8, 2018, unless reissued
  • The Health of Sexual and Gender Minority (SGM) Populations - expires September 8, 2018, unless reissued
  • Social Epigenomics Research Focused on Minority Health and Health Disparities - expires November 16, 2018, unless reissued
  • Mechanisms of Disparities in Chronic Liver Diseases and Cancer - expires April 5, 2019, unless reissued
  • Addressing Health Disparities through Effective Interventions among Immigrant Populations - expires January 8, 2020, unless reissued
  • Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations - expires January 8, 2020, unless reissued
  • Intervention Research to Improve Native American Health - expires May 15, 2020, unless reissued
  • U.S. Tobacco Control Policies to Reduce Health Disparities – expires June 16, 2020, unless reissued
  • Leveraging Population-based Cancer Registry Data to Study Health Disparities - expires September 8, 2020, unless reissued
  • Research on the Health of Transgender and Gender Nonconforming Populations - expires January 8, 2021, unless reissued

EGRP joins with other NCI Divisions, Offices, and Centers and other Institutes and Centers at the National Institutes of Health (NIH) to fund grant applications submitted in response to FOAs. View the full list of EGRP FOAs.

EGRP also encourages investigator-initiated grant applications on health disparities topics.

Return to Top

Funded Projects

The Epidemiology and Genomics Research Program (EGRP) supports a variety of research addressing health disparities. To learn more about EGRP's health disparities research portfolio, view a list of EGRP's active health disparities grantsExternal Web Site Policy.

Return to Top

Workshops and Webinars

Return to Top

Research Resources

NCI and NIH resources that may be of interest to investigators interested in health disparities research include:

Additionally, NCI's Division of Cancer Control and Population Sciences (DCCPS) offers the following tools to help investigators compare populations with respect to the distribution of risk factors and cancer risk.

Return to Top

Contacts

Staff in multiple EGRP Branches are interested in fostering research aimed at reducing cancer-related health disparities. Contacts include:

  • Social environment, variation in exposure to environmental toxicants, and biological processes that lead to cancer -
    Gary L. Ellison, Ph.D., M.P.H.
  • Disparities in health outcomes after cancer diagnosis, cancer survivorship, treatment toxicity -
    Lisa Gallicchio, Ph.D.
  • Cancer disparities in understudied populations, disparities in carcinogenic risk factors including infectious agents and lifestyle factors -
    Tram K. Lam, Ph.D., M.P.H.
  • Cancer disparities in underserved populations, cancer epidemiologic research in understudied populations, global health and cancer epidemiology, cancer registry development in the Caribbean -
    Damali N. Martin, Ph.D., M.P.H.
  • Biomarkers, epigenetics, metabolomics, proteomics, and risk assessment -
    Mukesh Verma, Ph.D.

Return to Top